COMMUNIQUÉS West-GlobeNewswire

Idorsia seeks US label update for QUVIVIQ daytime functioning benefits – first patients enrolled in Dari-Dream
27/10/2026
Building on established clinical evidence, Dari-Dream is designed to further characterize the impact of QUVIVIQ on daytime functioning and support its inclusion in the US prescribing information. Allschwil, Switzerland [...]
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
27/10/2026
2026 operating profit expected to reach CHF 115 million (previously CHF 70 million) driven by higher than expected Cresemba and Zevtera-related revenue of CHF 250 million (previously CHF 210 million) Cumulative cash [...]
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
27/10/2026
Ad hoc announcement pursuant to Art. 53 LR Third quarter Q3 net sales grew +4% (cc ¹ , +4% USD), with core operating income ¹ +10% (cc, +11% USD) Sales growth driven by priority brands including Kisqali (+37% cc), [...]
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
27/10/2026
Third quarter 2026 total revenues increased by 21% to US$117.6 million, compared to third quarter 2025, exceeding market expectations RUCONEST® revenue increased by 14% to US$93.8 million, compared to third quarter 2025 [...]
Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
27/10/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces an expert webcast, co-hosted with Citigroup Global [...]
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
26/10/2026
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 Mont-Saint-Guibert, Belgium – October 26, 2026, 10:05 pm CET / 5:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]
Nyxoah Publiera ses Résultats Financiers du Troisième Trimestre 2026 le 5 Novembre 2026
26/10/2026
Nyxoah Publiera ses Résultats Financiers du Troisième Trimestre 2026 le 5 Novembre 2026 Mont-Saint-Guibert, Belgique – 26 octobre 2026, 22h05 CET / 17h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou [...]
Onconetix Announces Reverse Stock Split
26/10/2026
CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s [...]
Onco360® Has Been Selected as a National Pharmacy Partner for ZEGFROVY® (sunvozertinib)
26/10/2026
LOUISVILLE, Ky., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca Pharmaceuticals for Zegfrovy ® ( [...]
Octane Biotech and Currus Biologics Automate Manufacturing of CUR-001 CAR T-Cell Therapy on the Cocoon® Platform
26/10/2026
Automated, closed-system process to support Currus’ Phase 1 trial in mesothelin-positive solid tumours, with first patient dosing expected in early 2027 KINGSTON, Ontario and MELBOURNE, Australia, Oct. 26, 2026 (GLOBE [...]
SL Science Holding Limited Reports First Half 2026 Financial Results
26/10/2026
Net revenue rose 23% to $1.39 million with gross margin expanding to 40.2%, driven by B2B distribution growth and reduction in purchase costs compared with last period due to establishment of stable relationships with [...]
Park Dental Partners Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
26/10/2026
MINNEAPOLIS, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended September [...]
Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
26/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics [...]
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
26/10/2026
WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, [...]
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
26/10/2026
BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market [...]
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
26/10/2026
Adds a radiology professional services platform offering teleradiology and in-hospital staffing for hospitals and health systems Enables RadNet to seamlessly combine radiology professional services, AI-powered [...]
BayCare to Become First Health System in Florida to Pilot Robotic Blood-Draw Technology
26/10/2026
CLEARWATER, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) -- BayCare, the largest not-for-profit academic health care system in West Central Florida, is developing plans to become the first health system in Florida to pilot [...]
MGMA Elects Audrey Fisher and Melanie Stohl as Directors-at-Large; Gena Graves as Vice Chair; Jeffrey Smith as Board Chair
26/10/2026
New board leaders bring expertise spanning physician practice management, healthcare operations, clinical leadership and advocacy as MGMA begins its second century. ENGLEWOOD, Colorado, Oct. 26, 2026 (GLOBE NEWSWIRE [...]
Eurobio Scientific : EB Development augmente le prix offert dans le cadre de l’offre publique de retrait suivie d’un retrait obligatoire portant sur les actions d’Eurobio Scientific
26/10/2026
EB Development augmente le prix offert dans le cadre de l’offre publique de retrait suivie d’un retrait obligatoire portant sur les actions d’Eurobio Scientific Paris, le 26 octobre 2026 – 18H30 À la suite du dépôt [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum